Biodegradable microspheres based on gelatin-porcine mucin admixtures: In vitro and in vivo delivery studies

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 10, 2009, Pages 1754-1759

  Ofokansi, Kenneth Chibuzor ^a,c   Okorie, Ogbonna ^b   Adikwu, Michael Umale ^a  

^a UNIVERSITY OF NIGERIA   (Nigeria)

^b UNIVERSITY OF PORT HARCOURT   (Nigeria)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Admixture; Biodegradable gelatin microsphere; Cefaclor; In vitro in vivo delivery; Porcine mucin

Indexed keywords

CEFACLOR; GELATIN; MICROSPHERE; MUCIN; PANCREATIN; PEPSIN A;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BIODEGRADABILITY; CENTRIFUGATION; CONTROLLED STUDY; CROSS LINKING; DIALYSIS; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; EMULSION; FREEZE DRYING; ILEUM; IN VITRO STUDY; IN VIVO STUDY; INTESTINE FLUID; MALE; MAXIMUM PLASMA CONCENTRATION; MUCOADHESION; NONHUMAN; RAT; STOMACH JUICE; SWINE; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, RECTAL; ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CEFACLOR; DRUG CARRIERS; GASTRIC JUICE; GELATIN; INTESTINE, SMALL; MICROSPHERES; MUCINS; RATS; RATS, WISTAR; SWINE;

EID: 70349943968     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.1754     Document Type: Article

References (29)

1. Cho M., Sah H., J. Microencapsul., 22, 1-9 (2005).
2. Zhu K., Li H. L., Jiang H., Yasuda A., Ichmaru A. K., Yamamoto P., Lecomte R. J. J. Microencapsul., 22, 25-33 (2005).
3. Chen Y., Lin X., J. Microencapsul., 22, 47-54 (2005).
4. Guo C. Y., Chan L. W., Heng P. W. S., J. Microencapsul., 22, 245-254 (2005).
5. Dinarvand R., Moghadam S. H., Sheikhf A., Atyabi F., J. Microencapsul., 22, 139-148 (2005).
6. Hari P. R., Chandy P., Sharma C. P., J. Appl. Polym. Sci., 59, 1795 - 1803 (1996).
7. Akydin Z., Akbuga J., Int. J. Pharm., 131, 101-109 (1996).
8. Myung-Kwan C., Hongkee S., Hoo-Kyun C., Int. J. Pharm., 297, 172-180 (2005).
9. Davis S. S., Illum L., Biomaterials, 9, 111-116 (1988).
10. Ritschel W. A., Drug Dev. Ind. Pharm., 15, 1073-1079 (1989).
11. Uchida T., Yoshida K., Goto K., J. Microencapsul., 13, 219-227 (1996).
12. Ogawa Y., Yamamoto M., Okada H., Yashiki T., Shimamoto T., Chem. Pharm. Bull., 36, 1095-1101 (1988).
13. Cohen S., Yoshioka Y., Lucarelli M., Hwang L. H., Langer R., Pharm. Res., 8, 713-718 (1991).
14. Patashnik L., Rabinovich L., Golonb G., J. Drug Target., 4, 371-378 (1997).
15. Stephen J. L., Brian P. F., Gordon G. F., Janet F. F., Biochem. J.. 175, 565-671 (1978).
16. Mortazari S. A., Capenter B. G., Smart J. D., Int. J. Pharm., 94, 195-202 (1993).
17. Forstner J. F., Forstner G. G., "Physiology of the Gastrointestinal Tract," 2nd ed., Raven Press, New York, 1994, pp. 1255-1280.
18. Carino G. P., Mathiowitz E., Adv. Drug Deliv. Rev., 35, 249-257 (1999).
19. Abata Y., Ikada Y., Pharm. Res., 6, 422-427 (1989).
20. Young S., Wong M., Tabata Y., Mikos A. G., J. Controlled Release, 109, 256-274 (2005).
21. De Blaey C. J., Tukker J. J., "Pharmaceutics, the Science of Dosage form Design," ed. By Aulton M. E., Churchill Livingstone, U.K., 1988, pp. 412-430.
22. Ofokansi K. C., Adikwu M. U., Okore V. C., Drug Dev. Ind. Pharm., 33, 691-700 (2007).
23. Stone S. H., Science, 119, 100-102 (1954).
24. Riley V., Proc. Soc. Exp. Biol. Med., 104, 751-754 (1960).
25. Tietz N. W., "Fundamentals of Clinical Chemistry," 2nd ed., Saunders WB Publishers, Philadelphia, 1970.
26. Tomlinson E., Burger J. J., "Polymers in Controlled Drug Delivery," ed. by Lisboth T., Davis S. S., Wright Publishing Company, Bristol, 1987, pp. 25-41.
27. Sokoliski T. D., "Microspheres and Drug Therapy," 2nd ed., Elsevier Science, Amsterdam, 1984.
28. Korsmeyer R. W., Gurny R., Doelker E., Buri P., Peppas N. A., Int. J. Pharm., 15, 25-35 (1985).
29. Langerbucker F. J., J. Pharm. Sci., 58, 1255-1260 (1989).